UCB: further rebound, Jefferies remains Buy

(CercleFinance.com) - The stock ended the day with a gain of almost +2%, benefiting from a favorable analysis by Jefferies.


Jefferies reaffirms its 'buy' recommendation on UCB, while raising its price target to 212 euros, in the wake of an increase in its peak sales forecast for Bimzelx to 7.2 billion euros, from 6.1 billion previously.

"With the recent divestment of legacy businesses, allowing us to focus more on growth drivers, we like the set-up for 2025 and think the share could go higher", the broker also believes.

Copyright (c) 2024 CercleFinance.com. All rights reserved.